Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI
Phase of Trial: Phase II
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Fluoxetine (Primary)
- Indications Respiration disorders
- Focus Therapeutic Use
- 14 Feb 2017 Status changed from not yet recruiting to recruiting.
- 09 Feb 2017 Planned number of patients changed from 80 to 100.
- 31 Jan 2017 Planned primary completion date changed from 1 Aug 2018 to 1 Jan 2019.